The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(4-Benzylpiperazin-1-yl)(2-(3-methoxyphenyl)-quinolin-4-yl)methanone ID: ALA4070968
PubChem CID: 1292979
Max Phase: Preclinical
Molecular Formula: C28H27N3O2
Molecular Weight: 437.54
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: COc1cccc(-c2cc(C(=O)N3CCN(Cc4ccccc4)CC3)c3ccccc3n2)c1
Standard InChI: InChI=1S/C28H27N3O2/c1-33-23-11-7-10-22(18-23)27-19-25(24-12-5-6-13-26(24)29-27)28(32)31-16-14-30(15-17-31)20-21-8-3-2-4-9-21/h2-13,18-19H,14-17,20H2,1H3
Standard InChI Key: VKSVJQOJUSUALE-UHFFFAOYSA-N
Molfile:
RDKit 2D
33 37 0 0 0 0 0 0 0 0999 V2000
16.0576 -3.8796 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0565 -4.7032 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7687 -5.1122 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7669 -3.4666 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.4796 -3.8760 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4804 -4.6991 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1889 -5.1062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9013 -4.6953 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8966 -3.8691 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1833 -3.4616 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3478 -3.4672 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3489 -2.6447 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6378 -2.2364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9251 -2.6452 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9279 -3.4708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6396 -3.8795 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7705 -5.9335 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0597 -6.3479 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.4833 -6.3446 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.2176 -3.8862 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.5084 -3.4761 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3475 -5.9341 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6388 -6.3450 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6364 -7.1667 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.3491 -7.5758 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0640 -7.1674 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9240 -7.5742 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2128 -7.1646 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2182 -6.3461 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5119 -5.9324 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7985 -6.3441 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8000 -7.1697 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5109 -7.5755 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
1 11 1 0
3 17 1 0
17 18 1 0
17 19 2 0
15 20 1 0
20 21 1 0
18 22 1 0
18 26 1 0
22 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
24 27 1 0
27 28 1 0
28 29 2 0
29 30 1 0
30 31 2 0
31 32 1 0
32 33 2 0
33 28 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 437.54Molecular Weight (Monoisotopic): 437.2103AlogP: 4.87#Rotatable Bonds: 5Polar Surface Area: 45.67Molecular Species: NEUTRALHBA: 4HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 6.93CX LogP: 4.88CX LogD: 4.75Aromatic Rings: 4Heavy Atoms: 33QED Weighted: 0.45Np Likeness Score: -1.42
References 1. Yamada K, Levell J, Yoon T, Kohls D, Yowe D, Rigel DF, Imase H, Yuan J, Yasoshima K, DiPetrillo K, Monovich L, Xu L, Zhu M, Kato M, Jain M, Idamakanti N, Taslimi P, Kawanami T, Argikar UA, Kunjathoor V, Xie X, Yagi YI, Iwaki Y, Robinson Z, Park HM.. (2017) Optimization of Allosteric With-No-Lysine (WNK) Kinase Inhibitors and Efficacy in Rodent Hypertension Models., 60 (16): [PMID:28771350 ] [10.1021/acs.jmedchem.7b00708 ]